Miriam Martini

Miriam Martini

Università degli Studi di Torino - Torino / Italy
Others
AD Scientific Index ID: 1809624
University of Turin
person_outline Miriam Martini's MOST POPULAR ARTICLES
1-) Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective …W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ...The lancet oncology 11 (8), 753-762, 201024002010
2-) Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal CancerF Di Nicolantonio, M Martini, F Molinari, A Sartore-Bianchi, S Arena, ...Journal of clinical oncology 26 (35), 5705-5712, 200821562008
3-) PI3K/AKT signaling pathway and cancer: an updated reviewM Martini, MC De Santis, L Braccini, F Gulluni, E HirschAnnals of medicine 46 (6), 372-383, 20149862014
4-) PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodiesA Sartore-Bianchi, M Martini, F Molinari, S Veronese, M Nichelatti, ...Cancer research 69 (5), 1851-1857, 20099442009
5-) Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancerA Sartore-Bianchi, F Di Nicolantonio, M Nichelatti, F Molinari, S De Dosso, ...PloS one 4 (10), e7287, 20093232009